-Thomas L Vaughan Researcher Activity Profile

Research Author Detailed Information 

Thomas L Vaughan Publication Rate By Year

Thomas L Vaughan has published 3 paper(s) in 2006, 10 paper(s) in 2007, for a total of 13 research publications in total.

Thomas L Tl Vaughan Author Information

LAST NAME: vaughan

FIRST NAME: Thomas L

INITIALS: tl

AFFILIATION:

Papers

Thomas L Vaughan's Publication Record

1. Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort study. Year Published: 2006
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA, USA. ckchang@cuhk.edu.hk
2. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Year Published: 2006
Division of Human Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, C1-157, Seattle, WA 98109, USA. dchao@fhcrc.org
3. Epidemiology and pathogenesis of esophageal cancer. Year Published: 2006
Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA.
4. Survival differences by race in nasopharyngeal carcinoma. Year Published: 2007
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. sunlm1010@yahoo.com.tw
5. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. Year Published: 2007
Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. pgal@fhcrc.org
6. Central adiposity and risk of Barrett's esophagus. Year Published: 2007
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
7. Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. Year Published: 2007
Mailman School of Public Health, Department of Epidemiology, Columbia University, 722 West 168th Street, Room 724A, New York, NY 10032, USA. mt146@columbia.edu
8. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Year Published: 2007
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, EPN 4005, 6130 Executive Boulevard, MSC 7344, Bethesda, MD 20892-7344, USA. Wideroff@nih.gov
9. Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus. Year Published: 2007
Program in Epidemiology (M4-874), Fred Hutchinson Cancer Research Center, P.O. Box 19024, Seattle, WA 98109. tvaughan@u.washington.edu.
10. Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. Year Published: 2007
Mailman School of Public Health, Department of Epidemiology, Columbia University, 722 West 168th Street, Room 724A, New York, NY 10032, USA. mt146@columbia.edu
11. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus. Year Published: 2007
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
12. Leukocyte Telomere Length Predicts Cancer Risk in Barrett's Esophagus. Year Published: 2007
Department of Pathology, University of Washington, Box 357705, 1959 Northeast Pacific Street, K-081 HSB, Seattle, WA 98195-7705. petersr@u.washington.edu.
13. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Year Published: 2007
Department of Pathology, University of Washington, Seattle, WA 98195-7705, USA.